Background: Atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS) criterion in thyroid fine-needle aspirates (FNAs) has been a heterogeneous entity with much inter-observer variation. Sub-categorisation of AUS/FLUS has been observed to play an effective role in risk stratification. We aimed to validate AUS/FLUS sub-categorisation in correlation with the spectrum of malignancy. Study Design: Subjects included patients with AUS/FLUS diagnosed between January 2015 and December 2016. AUS/FLUS cases were sub-categorised into those exhibiting (1) architectural atypia, (2) cytological atypia, (3) architectural and cytological atypia, (4) AUS with Hürthle cells, and (5) AUS not otherwise specified (AUS-NOS). Each sub-category was correlated with their corresponding incidence of malignancy in surgical resections. Result: The overall incidence of AUS/FLUS in our centre was 13% (132/1,018). On retrospective review of 117 patients with AUS/FLUS, smears with cytological atypia showed a higher incidence of malignancy (78.3%) than those with architectural atypia (75.3%). AUS/FLUS cases with both cytological and architectural atypia had a malignancy rate of 71.4%. Conclusion: AUS/FLUS cases with cytological atypia had a higher risk of malignancy than those with architectural atypia. The sub-categorisation of AUS/FLUS is diagnostically important for the proper risk stratification of patients.

1.
Unnikrishnan
AG
,
Menon
UV
.
Thyroid disorders in India: an epidemiological perspective
.
Indian J Endocrinol Metab
.
2011
Jul
;
15
(
6
Suppl 2
):
S78
81
.
[PubMed]
2230-8210
2.
Cibas
ES
,
Ali
SZ
.
The 2017 Bethesda System for Reporting Thyroid Cytopathology
.
Thyroid
.
2017
Nov
;
27
(
11
):
1341
6
.
[PubMed]
1050-7256
3.
Rangaswamy
M
,
Narendra
K
,
Patel
S
,
Gururajprasad
C
,
Manjunath
G
.
Insight to neoplastic thyroid lesions by fine needle aspiration cytology
.
J Cytol
.
2013
Jan
;
30
(
1
):
23
6
.
[PubMed]
0970-9371
4.
Agrawal
R
,
Saxena
M
,
Kumar
P
.
A Study of Fine Needle Aspiration Cytology of Thyroid Lesions with Histopathological Correlation
.
Indian J Pathol Oncol.
2015
;
2
(
4
):
277
.
5.
Gupta
M
,
Gupta
S
,
Gupta
VB
. Correlation of Fine Needle Aspiration Cytology with Histopathology in the Diagnosis of Solitary Thyroid Nodule. J Thyroid Res [Internet]. 2010 Apr 18 [cited 2016 Jul 12];
2010
.
6.
VanderLaan
PA
,
Marqusee
E
,
Krane
JF
.
Usefulness of diagnostic qualifiers for thyroid fine-needle aspirations with atypia of undetermined significance
.
Am J Clin Pathol
.
2011
Oct
;
136
(
4
):
572
7
.
[PubMed]
0002-9173
7.
Park
HJ
,
Moon
JH
,
Yom
CK
,
Kim
KH
,
Choi
JY
,
Choi
SI
, et al
Thyroid “atypia of undetermined significance” with nuclear atypia has high rates of malignancy and BRAF mutation
.
Cancer Cytopathol
.
2014
Jul
;
122
(
7
):
512
20
.
[PubMed]
1934-662X
8.
Renshaw
AA
.
Subclassification of atypical cells of undetermined significance in direct smears of fine-needle aspirations of the thyroid: distinct patterns and associated risk of malignancy
.
Cancer Cytopathol
.
2011
Oct
;
119
(
5
):
322
7
.
[PubMed]
1934-662X
9.
Wu
HH
,
Inman
A
,
Cramer
HM
.
Subclassification of “atypia of undetermined significance” in thyroid fine-needle aspirates
.
Diagn Cytopathol
.
2014
Jan
;
42
(
1
):
23
9
.
[PubMed]
8755-1039
10.
Olson
MT
,
Clark
DP
,
Erozan
YS
,
Ali
SZ
.
Spectrum of risk of malignancy in subcategories of ‘atypia of undetermined significance’
.
Acta Cytol
.
2011
;
55
(
6
):
518
25
.
[PubMed]
0001-5547
11.
Chandra
S
,
Chandra
H
,
Bisht
SS
.
Malignancy rate in thyroid nodules categorized as atypia of undetermined significance or follicular lesion of undetermined significance - An institutional experience
.
J Cytol
.
2017
Jul-Sep
;
34
(
3
):
144
8
.
[PubMed]
0970-9371
12.
Rosario
PW
,
Calsolari
MR
.
Importance of cytological subclassification of thyroid nodules with Bethesda category III cytology (AUS/FLUS) into architectural atypia only and nuclear atypia: A prospective study
.
Diagn Cytopathol
.
2017
Jul
;
45
(
7
):
604
7
.
[PubMed]
8755-1039
13.
Wong
LQ
, LiVolsi VA, Baloch ZW. Diagnosis of atypia/follicular lesion of undetermined significance: An institutional experience. CytoJournal [Internet].
2014
Aug 28 [cited 2017 Sep 3];11.
14.
Shrestha
RT
,
Hennessey
JV
.
Cytologic subclassification of atypia of undetermined significance may predict thyroid nodules more likely to be malignant at surgery
.
Diagn Cytopathol
.
2016
Jun
;
44
(
6
):
492
8
.
[PubMed]
8755-1039
15.
Cibas
ES
,
Ali
SZ
;
NCI Thyroid FNA State of the Science Conference
.
The Bethesda System For Reporting Thyroid Cytopathology
.
Am J Clin Pathol
.
2009
Nov
;
132
(
5
):
658
65
.
[PubMed]
0002-9173
16.
VanderLaan
PA
,
Marqusee
E
,
Krane
JF
.
Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated fna be the preferred initial approach?
Am J Clin Pathol
.
2011
May
;
135
(
5
):
770
5
.
[PubMed]
0002-9173
17.
Kapila
K
,
Qadan
L
,
Ali
RH
,
Jaragh
M
,
George
SS
,
Haji
BE
.
The Bethesda System for Reporting Thyroid Fine-Needle Aspiration Cytology: A Kuwaiti Experience - A Cytohistopathological Study of 374 Cases
.
Acta Cytol
.
2015
;
59
(
2
):
133
8
.
[PubMed]
0001-5547
18.
Jo
VY
,
Stelow
EB
,
Dustin
SM
,
Hanley
KZ
.
Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology
.
Am J Clin Pathol
.
2010
Sep
;
134
(
3
):
450
6
.
[PubMed]
0002-9173
19.
Jeong
SH
,
Hong
HS
,
Lee
EH
,
Cha
JG
,
Park
JS
,
Kwak
JJ
.
Outcome of thyroid nodules characterized as atypia of undetermined significance or follicular lesion of undetermined significance and correlation with Ultrasound features and BRAF(V600E) mutation analysis
.
AJR Am J Roentgenol
.
2013
Dec
;
201
(
6
):
W854-60
.
[PubMed]
0361-803X
20.
Hyeon
J
,
Ahn
S
,
Shin
JH
,
Oh
YL
.
The prediction of malignant risk in the category “atypia of undetermined significance/follicular lesion of undetermined significance” of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results
.
Cancer Cytopathol
.
2014
May
;
122
(
5
):
368
76
.
[PubMed]
1934-662X
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.